Zobrazeno 1 - 10
of 217
pro vyhledávání: '"L, Laterza"'
Case report: Dupilumab treatment improved type 2 disorders in a patient with IPEX syndrome diagnosis
Autor:
C. Caruso, L. Laterza, C. R. Settanni, S. Colantuono, C. Di Mario, B. Tolusso, F. Castrì, E. Gremese, F. Scaldaferri, A. Armuzzi, C. De Simone, K. Peris, A. Chiricozzi, A. Gasbarrini
Publikováno v:
Frontiers in Immunology, Vol 13 (2023)
We described a case of IPEX syndrome successfully controlled with dupilumab, an anti-IL4 receptor alpha subunit inhibitor. IPEX syndrome is a rare and generally fatal genetic disorder characterized by immune dysregulation, polyendocrinopathy and ente
Externí odkaz:
https://doaj.org/article/96e741e104df4a0583ef8abba24751dc
Publikováno v:
Journal of Functional Foods, Vol 47, Iss , Pp 531-546 (2018)
Gut microbiota dysfunction is associated with multiple gastrointestinal and extra-gastrointestinal diseases, thus the possibility of its modulation with prebiotics, probiotics and symbiotics has gained interest in the last years. Many probiotics are
Externí odkaz:
https://doaj.org/article/7bb98e3cbc48403eb3ba5d00bf88ea4c
Autor:
D Napolitano, E Schiavoni, L Laterza, V Mora, L Sofo, D Pugliese, A Gasbarrini, F Scaldaferri
Publikováno v:
Journal of Crohn's and Colitis. 17:i1042-i1044
Background A multidisciplinary team (MT) approach has increasingly taken a prominent role in the management of IBD patients, providing a complete level of assistance. A key figure is represented by the IBD care Managers (ICM), who is usually an indep
Autor:
L. Laterza, A. Gasbarrini
Publikováno v:
CellR4, Vol 7 (2019)
Inflammatory bowel diseases (IBD) are chronic and invalidating diseases frequently needing continuative immunosuppressive therapy. Available therapies are not free from possible side effects, thus nutritional management is often advocated by patients
Externí odkaz:
https://doaj.org/article/4fab6cebe8f541edaf70f5d16ce4f705
Autor:
I Mignini, L Masucci, F De Maio, L Laterza, F Scaldaferri, C R Settanni, D Napolitano, S Baroni, M Garcovich, L Riccardi, A Gasbarrini, P M Ferraro, A Papa
Publikováno v:
Journal of Crohn's and Colitis. 17:i405-i406
Background Nephrolithiasis (NL) is a common extra-intestinal complication of inflammatory bowel disease (IBD) with recognizable morbidity and mortality. However, its pathogenesis and risk factors are not completely elucidated yet. Because of intestin
Autor:
D Napolitano, A Cocchieri, N Orgiana, C Fanali, A Poscia, E Schiavoni, T Bernabei, V Amatucci, L Turchini, E Durini, M Strazzeri, L Laterza, L R Lopetuso, V Mora, A Papa, D Pugliese, A Gasbarrini, F Scaldaferri
Publikováno v:
Journal of Crohn's and Colitis. 17:i1047-i1048
Background Inflammatory Bowel Disease (IBD) management requires a multidisciplinary team, in which nurses have a pivotal role. Although patient care is the main focus of all clinical actions, satisfaction with healthcare professionals is an aspect of
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
L. Laterza, F. Di Vincenzo, R. Maresca, M.C. Russo, V. Mora, V. Petito, L. Turchini, V. Amatucci, D. Napolitano, E. Schiavoni, C. Settanni, L. Parisio, M. Pizzoferrato, L. Lopetuso, A. Armuzzi, A. Gasbarrini, D. Pugliese, F. Scaldaferri
Publikováno v:
Digestive and Liver Disease. 55:S94
Autor:
L. Pasquale, G. Grande, B. Germana, R.M. Zagari, A. Pisani, G. Cengia, E. Ciliberto, P. Da Massa Carrara, A. Lamazza, R. Conigliaro, L. Laterza, C. Stillitano, D. Picascia, M. Carati, E. Dal Pont, G. Galloro
Publikováno v:
Digestive and Liver Disease. 55:S151
Autor:
L. Pasquale, G. Grande, R.M. Zagari, A. Pisani, P. Da Massa Carrara, B. Germanà, E. Ciliberto, G. Cengia, A. Lamazza, L. Laterza, C. Stillitano, D. Picascia, R. Conigliaro, G. Galloro
Publikováno v:
ESGE Days 2022.